Share Purchase Agreement under which Lifeward agreed to acquire all outstanding equity interests of OraTech, a former wholly-owned subsidiary of the Company, after the Company transferred POD technology assets and funding to OraTech.
| Officer | Age | In this role | Joined | Source |
|---|---|---|---|---|
|
Nadav Kidron
Also a director
President, Chief Executive Officer, Director and Chairman
|
51 | Not stated | Not stated | |
|
Avraham Gabay
Chief Financial Officer and Treasurer
|
41 |
Since 2024
2 years
|
Not stated | |
|
Miriam Kidron
Also a director
Chief Scientific Officer and Director
|
85 |
Since 2006
20 years
|
Not stated | |
|
Joshua Hexter
COO & CBO
Title from the Form 4 dated Nov 12, 2026
|
55 | Not stated | 2013 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Share Purchase Agreement under which Lifeward agreed to acquire all outstanding equity interests of OraTech, a former wholly-owned subsidiary of the Company, after the Company transferred POD technology assets and funding to OraTech.
Lifeward issued shares, pre-funded warrants, warrants and revenue-sharing rights to the Company as consideration for the OraTech acquisition.
Lifeward issued senior secured convertible notes and warrants to the Company, with a further $9.0 million note funding possible on milestones.
Loading...